Accommodating risk: Responses to BRCA1/2 genetic testing of women who have had cancer

Social Science and Medicine

Volumn 59, Issue 3, 2004, Pages 553-565

  Hallowell, N ^a   Foster, C ^b   Eeles, R ^b   Ardern Jones, A ^c   Watson, M ^c  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

BRCA1 2 genetic testing; Breast cancer; Cancer patients; Risk perception; UK

Indexed keywords

ANTINEOPLASTIC AGENT; BRCA1 PROTEIN; BRCA2 PROTEIN;

CANCER; RISK FACTOR; TESTING METHOD;

ANXIETY; AWARENESS; BREAST CANCER; CANCER DIAGNOSIS; CANCER FAMILY; CANCER GENETICS; CANCER PATIENT; CANCER RISK; CANCER SCREENING; CANCER THERAPY; DNA DETERMINATION; FATALITY; FUTUROLOGY; GENE MUTATION; GENETIC RISK; HEALTH BEHAVIOR; HUMAN; INTERVIEW; LEARNING; METASTASIS; OVARY CANCER; PERCEPTION; POPULATION RISK; QUALITATIVE ANALYSIS; REACTION ANALYSIS; REVIEW; RISK REDUCTION;

EURASIA; EUROPE; UNITED KINGDOM; WESTERN EUROPE;

EID: 2442521134     PISSN: 02779536     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.socscimed.2003.11.025     Document Type: Article

References (42)

1. Appleton S., Fry A., Rees G., Rush R., Cull A. Psychosocial effects of living with an increased risk of breast cancer. An exploratory study using telephone focus groups Psycho-oncology. 9:2000;511-521
2. Beck U. Risk society. Towards a new modernity:1992;Sage, London
3. Bish A., Sutton S., Levene S., Ramirez A., Hodgson S. Changes in psychological distress after cancer genetic counselling. A comparison of affected and unaffected women British Journal of Cancer. 86:2002;43-50
4. Bonadona V., Salterl P., Desseigne F., Mignotte H., Saurin J.C., Wang Q., Sinilikova O., Giraud S., Freyer G., Plauchu H., Puisieux A., Lasset C. Cancer Epidemiology Biomarkers & Prevention. 11:2002;97-104
5. Brandt R., Hartmann E., Ali Z., Tucci R., Gilman P. Motivations and concerns of women considering genetic testing for breast cancer. A comparison between affected and at-risk probands Genetic Testing. 6:2002;203-205
6. Burke W., Daly M., Garber J., Botkin J., Kahn M.J., Lynch P., McTiernan A., Offit K., Perlman J., Petersen G., Thomson E., Varricchio C. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II BRCA1 and BRCA2. Journal of the American Medical Association. 277:1997;997-1003
7. Bury M. Chronic illness as biographical disruption. Sociology of Health & Illness. 4:1982;167-182
8. Butow P.N., Lobb E.A., Meiser B., Barratt A., Tucker K.M. Psychological outcomes and risk perception after genetic testing and counselling in breast cancer. A systematic review Medical Journal of Australia. 178:2003;77-81
9. Colyer H. Women's experience of living with cancer. Journal of Advanced Nursing. 23:1996;496-501
10. Corbin J., Strauss A. Accompaniments of chronic illness. Changes in body, self, biography, and biographical time Research in the Sociology of Health Care. 6:1987;249-281
11. Croyle R.T., Smith K.R., Botkin J.R., Baty B., Nash J. Psychological responses to BRCA1 mutation testing. Preliminary findings Health Psychology. 16:1997;63-72
12. Davison C., Frankel S., Davey Smith G. The limits of lifestyle. Re-assessing fatalism in the popular culture of illness prevention Social Science & Medicine. 34:1992;675-685
13. Di Prospero L.S., Seminsky M., Honeyford J., Doan B., Franssen E., Meschino W., Chart P., Warner E. Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations. Findings from a focus group and a needs-assessment survey Canadian Medical Association Journal. 164(7):2001;1005-1009
14. Dorval M., Patenaude A.F., Schneider K.A., Kieffer S.A., DiGianni L., Kalkbrenner K.J., Bromberg J.I., Basili L.A., Clazone K., Stofer J., Weber B.L., Garber J.E. Anticipated versus actual emotional reactions to disclosure of results of genetic tests for cancer susceptibility. Findings from p53 and BRCA1 testing programs Journal of Clinical Oncology. 18:2000;2135-2142
15. Eccles, Evans, D.G.R., Mackay, J. (2000). Guidelines for a genetic risk based approach to advising women with a family history of breast cancer. UK Cancer Family Study Group (UKCFSG). Journal of Medical Genetics, 37, 203-209.
16. Ford D., Easton D.F., Peto J. Estimates of gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. American Journal of Human Genetics. 57:1995;1457-1462
17. Ford, D., Easton, D.F., Stratton, M., Narod, S., Goldgar, D., Devilee, P., the Breast Cancer Linkage Consortium (1997). Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. American Journal of Human Genetics, 62, 676-689.
18. Foster C., Evans D.G.R., Eeles R., Eccles D., Ashley S., Brooks L., Davidson R., Mackay J., Morrison P.J., Watson M. Predicitve testing for BRCA1/2. Attributes, risk perception and management in a multi-centre clinical cohort British Journal of Cancer. 86:2002;1209-1216
19. Fry A., Rush R., Busby-Earle C., Cull A. Deciding about prophylactic oophorectomy. What is important to women at increased risk of ovarian cancer? Preventive Medicine. 33:2001;578-585
20. Giddens A. The consequences of modernity. 1990;Polity, Cambridge
21. Giddens A. Modernity and self-identity. Self and society in the late modern age:1991;Polity Press, Cambridge
22. Gifford S.M. The meaning of lumps. A case study in the ambiguities of risk Janes C.R., Stall R., Gifford S.M. Anthropology and epidemiology. 1986;D.Reidel, Dordrecht
23. Hallowell N., Foster C., Eeles R., Ardern-Jones A., Murday V., Watson M. Genetic testing for women previously diagnosed with breast/ovarian cancer. Examining the impact of BRCA1 and BRCA2 mutation searching Genetic Testing. 6(2):2002;79-87
24. Hallowell N., Foster C., Eeles R., Ardern-Jones A., Murday V., Watson M. Balancing autonomy and responsibility. The ethics of generating and disclosing genetic information Journal of Medical Ethics. 29:2003;74-79
25. Hallowell N., Jacobs I., Richards M.P.M., Mackay J., Gore M. Surveillance or surgery? A description of the factors that influence high-risk premenopausal women's decisions about prophylactic oophorectomy. Journal of Medical Genetics. 38:2001;683-691
26. Hatcher M., Fallowfield L., A'Hern R. The psychosocial impact of bilateral prophylactic mastectomy. Prospective study using questionnaires and semi-structured interviews BMJ. 322:2001;76
27. Kavanagh A.M., Broom D.H. Embodied risk. My body, myself? Social Science & Medicine. 46:1998;437-444
28. Koenig B.A., Stockdale A. The promise of molecular medicine in preventing disease. Examining the burden of genetic risk Callahan D. Promoting healthy behaviour: How much freedom? Whose responsibility? 2000;116-137 Georgetown University Press, Washington, DC
29. Lawton J. Lay experiences of health and illness. Past research and future agendas Sociology of Health & Illness. 25:2003;23-40
30. Leder D. The absent body. 1990;University of Chicago Press, Chicago
31. Lodder L., Frets P.G., Trijsburg R.W., Meijers-Heijboer E.J., Klijn J.G., Duivenvoorden H.J., Tibben A., Wagner A., van der Meer C.A., van den Ouweland A.M., Niermeijer M.F. Psychological impact of receiving a BRCA1/BRCA2 test result. American Journal of Medical Genetics. 98:2001;15-24
32. Mathieson C.M., Stam H.J. Renegotiating identity. Cancer narratives Sociology of Health & Illness. 17:1995;283-306
33. Meiser B., Butow P., Barratt A., Friedlander M., Gattas M., Kirk J., Suthers G., Walpole I., Tucker K. Attitudes toward prophylactic oophorectomy and screening utilization in women at increased risk of developing hereditary breast/ovarian cancer. Gynecological Oncology. 75:1999;122-129
34. Novas C., Rose N. Genetic risk and the birth of the somatic individual. Economy and Society. 29:2000;485-513
35. Pierret J. Interviews and biographical time. The case of long-term HIV nonprogressors Sociology of Health & Illness. 23:2001;159-179
36. Petersen A., &Bunton R. The new genetics and the public's health. 2002;Routledge, London
37. Stefanek M.E. Bilateral prophylactic mastectomy. Issues and concerns Monographs of the National Cancer Institute. 17:1995;37-42
38. Strauss A., &Corbin J. Basics of qualitative research. 1990;Sage, London
39. Watson M., Lloyd S., Davidson J., Meyer L., Eeles R., Ebbs S., Murday V. The impact of genetic counselling on risk perception and mental health in women with a family history of breast cancer. British Journal of Cancer. 79:1999;868-874
40. Whittemore A.S., Gong G., Itnyre J. Prevalence and contribution of BRCA1 mutations in breast and ovarian cancer. Results from three us population-based case-control studies of ovarian cancer American Journal of Human Genetics. 60:1998;496-504
41. Wilkinson I. Anxiety in a risk society. 2001;Routledge, London
42. Williams G. The genesis of chronic illness. Narrative re-construction Sociology of Health & Illness. 6:1984;175-200